Paper Details

  1. Home
  2. Paper Details

Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials.

Author: Ben-ShlomoYoav, BreenKieran, ClarkeCarl E, IvesNatalie, PatelSmitaa, ReesKaren, StoweRebecca

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

While current treatments for Parkinson's disease (PD) focus on managing symptoms, there is no widely accepted treatment to stop or slow the progression of the disease. Preclinical studies have identified potential neuroprotective or disease-modifying agents, including some anti-hypertension medications.
Paper Details　
Original Abstract of the Article :
Current treatment for Parkinson's disease (PD) is focused on relieving symptoms, at present there is nothing that is widely accepted to halt or slow disease progression. Potential neuroprotective or disease modifying agents have been identified from preclinical studies. One such group of compounds a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD008535.pub2

データ提供：米国国立医学図書館（NLM）

Anti-Hypertensive Drugs: A New Path in Parkinson's Disease Treatment?

Parkinson's disease (PD) is a debilitating neurodegenerative disorder, a journey through a desert of physical and mental challenges. Current treatments primarily focus on symptom management, but the search for therapies that can halt or slow disease progression continues.

This study delves into the potential of anti-hypertensive drugs, commonly used to treat high blood pressure, as disease-modifying agents for PD. The researchers meticulously examine existing observational studies and clinical trials, searching for evidence that these drugs might have a positive impact on the course of PD. It's like exploring a new route through the desert, seeking a hidden oasis that could alleviate the symptoms and slow the progression of this challenging condition.

Hope on the Horizon: Anti-Hypertensive Drugs as Disease Modifiers

While the evidence is still emerging, this study suggests that anti-hypertensive drugs may hold promise as disease-modifying agents for PD. Preliminary findings from both observational studies and clinical trials indicate that these drugs may play a role in slowing the progression of PD, offering a glimmer of hope in the fight against this debilitating condition. It's like finding a hidden oasis in the desert, providing relief from the harsh realities of this journey.

Navigating the Desert of Parkinson's Disease

This study is a testament to the persistent search for effective treatments for PD. While further research is needed to fully understand the potential benefits and mechanisms of action of anti-hypertensive drugs, these findings provide valuable insights and a new avenue for exploration. Navigating the desert of Parkinson's disease is a challenging journey, but with continued research and innovation, we may find new paths that lead to better outcomes.

Dr. Camel's Conclusion

This study offers a glimmer of hope for those navigating the desert of Parkinson's disease. The potential of anti-hypertensive drugs as disease-modifying agents is a promising avenue for research, but it's important to remember that the journey toward effective treatments is long and complex.

Date :
  1. Date Completed 2012-05-11
  2. Date Revised 2022-01-29
Further Info :

Pubmed ID

22071852

DOI: Digital Object Identifier

10.1002/14651858.CD008535.pub2

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.